FDA Expositions Inc

EIN: 934416243 501(c)(3) Public & Societal Benefit

Baltimore, MD

Total Revenue
$511,000
Total Expenses
$454,431
Total Assets
$109,207
Net Assets
$109,207
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2024
Legal Domicile
MD
Principal Officer
Matthew Flemister
Phone
4436902352
Tax Period
2025-01-01 to 2025-12-31

FDA Expositions Inc, founded in 2024, is a small nonprofit in the Public & Societal Benefit sector that reported $511K in total revenue in fiscal year 2025. Revenue grew 11% year-over-year, indicating healthy expansion. Expenses of $454K left a modest 11% surplus.

Mission

bringing technology vendors together with military and government personnel through the most targeted, interactive and well attended onsite technology expositions available

Program Service Accomplishments

Program 1
Expenses: $404,431

bringing technology vendors together with military and government personnel through the most targeted, interactive and well attended onsite technology expositions available

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $511,000
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $511,000

Expense Breakdown

Grants Paid $0
Salaries & Benefits $304,406
Fundraising Expenses $0
Program Expenses $404,431
Other Expenses $150,025
TOTAL EXPENSES $454,431

Year-over-Year Comparison

2025 2024 Change
Revenue $511,000 $458,747 +0.1%
Expenses $454,431 $406,109 +0.1%
Net Income $56,569 $52,638 +0.1%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
2
Independent Members
N/A
Employees
2
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$283,000
Total Directors
2
$283,000
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Matthew S Flemister President 40.00
Officer Director
$188,000 $0 $188,000
Jade N Ruiz Vice President 40.00
Officer Director
$95,000 $0 $95,000
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $511,000 $454,431 $109,207 $56,569
2024 $458,747 $406,109 $52,638 $52,638
Explore More Nonprofits
→Top 100 Nonprofits in Maryland →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare FDA Expositions Inc with other nonprofits in Maryland and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.